<DOC>
	<DOCNO>NCT00698633</DOCNO>
	<brief_summary>The purpose prospective clinical data collection document performance clinical outcome M2a- Taper™ Hip System</brief_summary>
	<brief_title>A Clinical Investigation M2a- Taper™ Hip System</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patients primary cement cementless total hip replacement noninflammatory degenerative joint disease ( NIDJD ) , composite diagnosis : 1 . Osteoarthritis , 2 . Avascular Necrosis , 3 . Traumatic arthritis , 4 . Subcapital fracture , 5 . Legg Perthes , 6 . Slipped Capital Epiphysis , 7 . Fracture pelvis , 8 . Diastrophic Variant Patients full skeletal maturity . Patients undergo unilateral total hip arthroplasty bilateral total hip arthroplasty , either stag simultaneously . Patients race gender . Patients able follow postoperative care instruction . Patients able willing return followup evaluation . Patients preoperative total Harris Hip Score less 70 least moderate pain . Exclusion Criteria Patients diagnose inflammatory degenerative arthritis ( IDJD ) include follow composite diagnosis : rheumatoid arthritis , systemic lupus erythematous , pigment villonodular synovitis , juvenile rheumatoid arthritis arthritic process inflammatory autoimmune etiology . Patients le 18 year . Patients presence previous prosthetic hip replacement device ( type , include surface replacement arthroplasty , endoprosthesis , etc . ) hip joint operate . Patients previous Girdlestone procedure . Patients knee amputation contralateral and/or ipsilateral leg . Patients osteoporosis , mark bone loss would preclude proper fixation prosthesis . Patients pregnant . Patients active suspected infection around hip . Patients Parkinson 's disease . Patients vascular insufficiency , muscular atrophy , neuromuscular disease affect limb . Patients severe instability deformity ligament and/or surround soft tissue would prelude stability prosthesis . Patients highly communicable disease disease may limit followup ( e.g . immunocompromised condition , hepatitis , active tuberculosis , neoplastic disease , etc. ) . Patients unwilling unable comply rehabilitation program cement cementless total hip replacement indicate difficulty inability return followup visit prescribe study protocol . Patients previous hip surgery condition may interfere total hip replacement 's survival outcome , e.g. , Paget 's disease , Charcot 's disease , severe osteoporosis compromise bone stock ( Dorr type C bone ) . Patients qualify inclusion study , refuse consent participate study . Patients `` fuse '' hip . Patients total hip arthroplasty contralateral hip within last year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Hip arthroplasty</keyword>
</DOC>